These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Harada H; Nakagawa H; Oyama K; Takaoka M; Andl CD; Jacobmeier B; von Werder A; Enders GH; Opitz OG; Rustgi AK Mol Cancer Res; 2003 Aug; 1(10):729-38. PubMed ID: 12939398 [TBL] [Abstract][Full Text] [Related]
9. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells. Horner SM; DeFilippis RA; Manuelidis L; DiMaio D J Virol; 2004 Apr; 78(8):4063-73. PubMed ID: 15047823 [TBL] [Abstract][Full Text] [Related]
10. Telomeres, telomerase, and myc. An update. Cerni C Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922 [TBL] [Abstract][Full Text] [Related]
11. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976 [TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) and the control of cellular proliferative life span. Huschtscha LI; Reddel RR Carcinogenesis; 1999 Jun; 20(6):921-6. PubMed ID: 10357768 [TBL] [Abstract][Full Text] [Related]
14. Tumor suppressors and oncogenes in cellular senescence. Bringold F; Serrano M Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053 [TBL] [Abstract][Full Text] [Related]
15. The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Parkinson EK; Newbold RF; Keith WN Eur J Cancer; 1997 Apr; 33(5):727-34. PubMed ID: 9282111 [TBL] [Abstract][Full Text] [Related]
16. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression. Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969 [TBL] [Abstract][Full Text] [Related]